Bypassing multidrug resistance in human breast cancer cells with lipid/polymer particle assemblies
Bo Li1, Hui Xu2, Zhen Li1, Mingfei Yao1, Meng Xie1, Haijun Shen1, Song Shen1, Xinshi Wang1, Yi Jin11College of Pharmaceutical sciences, Zhejiang University, Hangzhou, 2No. 202 Hospital of People's Liberation Army, Shenyang, ChinaBackground: Multidrug resistance (MDR) mediated by the over...
Guardado en:
Autores principales: | Li B, Xu H, Li Z, Yao M, Xie M, Shen H, Shen S, Wang X, Jin Y |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cf72ae370cf448c0a1ddda777e398844 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nanostructured lipid carriers co-delivering lapachone and doxorubicin for overcoming multidrug resistance in breast cancer therapy
por: Li X, et al.
Publicado: (2018) -
Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells
por: Yuan Y, et al.
Publicado: (2019) -
Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system
por: Guo L, et al.
Publicado: (2015) -
Multidrug-resistant breast cancer: current perspectives
por: Martin HL, et al.
Publicado: (2014) -
Enhanced anticancer activity and intracellular uptake of paclitaxel-containing solid lipid nanoparticles in multidrug-resistant breast cancer cells
por: Xu W, et al.
Publicado: (2018)